Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Canetti, D."'
Autor:
Lavatelli F; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy; Research Area, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: francesca.lavatelli@unipv.it., Natalello A; Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy. Electronic address: antonino.natalello@unimib.it., Marchese L; Pathology Unit, Fondazione IRCSS Policlinico San Matteo, Pavia, Italy., Ami D; Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy., Corazza A; Department of Medicine (DAME), University of Udine, Udine, Italy; Istituto Nazionale Biostrutture e Biosistemi, Roma, Italy., Raimondi S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Mimmi MC; Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Malinverni S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Mangione PP; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy; Research Area, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Palmer MT; Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy., Lampis A; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Concardi M; Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Verona G; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy; Centre for Amyloidosis, Division of Medicine, University College London, London, UK., Canetti D; Centre for Amyloidosis, Division of Medicine, University College London, London, UK., Arbustini E; Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Bellotti V; Research Area, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Giorgetti S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy; Research Area, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: s.giorgetti@unipv.it.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Apr; Vol. 300 (4), pp. 107174. Date of Electronic Publication: 2024 Mar 16.
Autor:
Slamova I; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Adib R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; London Institute of Medical Sciences, Imperial College London, London, UK., Ellmerich S; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Golos MR; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; School of Biological Sciences, University of Bristol, Bristol, UK., Gilbertson JA; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Botcher N; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Canetti D; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Taylor GW; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Rendell N; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Tennent GA; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Verona G; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Porcari R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Mangione PP; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Gillmore JD; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Pepys MB; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Bellotti V; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Hawkins PN; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Al-Shawi R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Simons JP; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK. p.simons@ucl.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Dec 07; Vol. 12 (1), pp. 7112. Date of Electronic Publication: 2021 Dec 07.
Autor:
Moura A; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Nocerino P; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Gilbertson JA; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Rendell NB; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Mangione PP; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Verona G; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Rowczenio D; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Gillmore JD; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Taylor GW; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Bellotti V; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Canetti D; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Publikováno v:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2020 Sep; Vol. 27 (3), pp. 206-207. Date of Electronic Publication: 2020 Feb 18.
Autor:
Raimondi S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Mangione PP; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Verona G; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Canetti D; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Nocerino P; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Marchese L; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Piccarducci R; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.; Department of Pharmacy, University of Pisa, Pisa, Italy., Mondani V; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Faravelli G; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Taylor GW; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Gillmore JD; National Amyloidosis Centre, University College London and Royal Free Hospital, London, United Kingdom., Corazza A; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.; Department of Medicine (DAME), University of Udine, Udine, Italy.; Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy., Pepys MB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.; National Amyloidosis Centre, University College London and Royal Free Hospital, London, United Kingdom., Giorgetti S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy s.giorgetti@unipv.it v.bellotti@ucl.ac.uk.; Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy., Bellotti V; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy s.giorgetti@unipv.it v.bellotti@ucl.ac.uk.; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2020 Aug 14; Vol. 295 (33), pp. 11379-11387. Date of Electronic Publication: 2020 Jun 22.
Autor:
Canetti D; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK.; c Department of Molecular Medicine , Institute of Biochemistry, University of Pavia , Pavia , Italy.; d CEINGE , University of Naples , Naples , Italy.; e Department of Chemical Sciences , University of Naples , Naples , Italy., Rendell NB; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Di Vagno L; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Gilbertson JA; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Rowczenio D; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Rezk T; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Gillmore JD; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Hawkins PN; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Verona G; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK., Mangione PP; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK.; c Department of Molecular Medicine , Institute of Biochemistry, University of Pavia , Pavia , Italy., Giorgetti S; c Department of Molecular Medicine , Institute of Biochemistry, University of Pavia , Pavia , Italy., Mauri P; f Proteomics and Metabolomics Laboratory , CNR-ITB , Segrate , Italy., Motta S; f Proteomics and Metabolomics Laboratory , CNR-ITB , Segrate , Italy., De Palma A; f Proteomics and Metabolomics Laboratory , CNR-ITB , Segrate , Italy., Bellotti V; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK.; c Department of Molecular Medicine , Institute of Biochemistry, University of Pavia , Pavia , Italy., Taylor GW; a Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.; b National Amyloidosis Centre, Division of Medicine , University College London , London , UK.
Publikováno v:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2017 Dec; Vol. 24 (4), pp. 233-241. Date of Electronic Publication: 2017 Oct 10.
Autor:
Mangione PP; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, UK; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Mazza G; Institute for Liver and Digestive Health, University College London, London, UK., Gilbertson JA; National Amyloidosis Centre, University College London and Royal Free Hospital, London, UK., Rendell NB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, UK., Canetti D; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, UK; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy; CEINGE and Department of Chemical Sciences, University of Naples, Naples, Italy., Giorgetti S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Frenguelli L; Institute for Liver and Digestive Health, University College London, London, UK., Curti M; Institute for Liver and Digestive Health, University College London, London, UK., Rezk T; National Amyloidosis Centre, University College London and Royal Free Hospital, London, UK., Raimondi S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Pepys MB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, UK; National Amyloidosis Centre, University College London and Royal Free Hospital, London, UK., Hawkins PN; National Amyloidosis Centre, University College London and Royal Free Hospital, London, UK., Gillmore JD; National Amyloidosis Centre, University College London and Royal Free Hospital, London, UK., Taylor GW; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, UK., Pinzani M; Institute for Liver and Digestive Health, University College London, London, UK. Electronic address: m.pinzani@ucl.ac.uk., Bellotti V; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, UK; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy. Electronic address: v.bellotti@ucl.ac.uk.
Publikováno v:
Journal of proteomics [J Proteomics] 2017 Aug 08; Vol. 165, pp. 113-118. Date of Electronic Publication: 2017 Jun 21.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.